Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus
Concetta Sciammarella(Inserm), Anna Grimaldi(Scuola Superiore Meridionale), Anna Capasso, Ján Fedačko(University of Pavol Jozef Šafárik), Antongiulio Faggiano(European Neuroendocrine Tumor Society), Amalia Luce(University of Campania "Luigi Vanvitelli"), Pierpaolo Correale(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Gabriella Misso(University of Campania "Luigi Vanvitelli"), Roberta Modica(University of Naples Federico II), Massimiliano Berretta(University of Messina), Annamaria Colao(European Gravitational Observatory), Alois Nečas(University of Veterinary Sciences Brno), Michele Caraglia(University of Campania "Luigi Vanvitelli"), Carmela Mocerino(Ospedale Antonio Cardarelli), Alessia Maria Cossu(University of Campania "Luigi Vanvitelli"), Giovanni Vitale(University of Milan), Ferdinando Riccardi(Ospedale Antonio Cardarelli)
Cited by 22
Related Papers
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
|Endocrine Reviews|2004|1.3k
Persistence of Increased Cardiovascular Risk in Patients with Cushing’s Disease after Five Years of Successful Cure
|The Journal of Clinical Endocrinology & Metabolism|1999|417
Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission
|The Journal of Clinical Endocrinology & Metabolism|2003|355
The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
|The Journal of Clinical Endocrinology & Metabolism|2008|326